Screening for Diabetes in General Practice
Open Access
- 1 April 2003
- journal article
- review article
- Published by Wiley in Preventive Cardiology
- Vol. 6 (2), 78-84
- https://doi.org/10.1111/j.1520-037x.2003.01662.x
Abstract
The prevalence of type 2 diabetes is rising rapidly worldwide. Evidence suggests that between one third and one half of cases are undiagnosed and patients may have preclinical disease for as long as 12 years. At diagnosis, 50% of patients have microvascular complications (retinopathy, neuropathy, or nephropathy) and patients have twice the risk of macrovascular disease compared to the background population. Screening for type 2 diabetes would allow earlier recognition of cases, with the potential to intervene earlier in the disease course, but whether this would result in improved long‐term outcomes is unknown. The debate continues about who should be considered for screening, how we should screen, and whether we should screen for diabetes at all. The authors review the evidence, particularly in light of the recent position statement on diabetes screening published by the American Diabetes Association. If we do start screening for diabetes, one of the major challenges ahead is to ensure resources are in place to allow optimization of treatment for the increasing number of patients. This is important both in those found to have diabetes and in those with lesser degrees of glucose intolerance who are at high risk of developing diabetes and are at increased risk of macrovascular disease.Keywords
This publication has 55 references indexed in Scilit:
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- American Diabetes Association diabetes diagnostic criteria, advancing age, and cardiovascular disease risk profiles: results from the Third National Health and Nutrition Examination Survey.Diabetes Care, 2000
- LetterDiabetic Medicine, 1999
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998
- Screening for Diabetes Mellitus in Adults: The utility of random capillary blood glucose measurementsDiabetes Care, 1995
- Frequency and Determinants of Screening for Diabetes in the U.SDiabetes Care, 1994
- Community Screening for Diabetes: Low detection rate in a low-risk populationDiabetes Care, 1994
- Self testing for diabetes mellitus.BMJ, 1991
- Screening for Diabetes: Does Measurement of Serum Fructosamine Help?Diabetic Medicine, 1988